These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition. HORITA A Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854 [No Abstract] [Full Text] [Related]
9. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide. DEWHURST WG; PARE CM J Ment Sci; 1961 Mar; 107():239-43. PubMed ID: 13722403 [No Abstract] [Full Text] [Related]
10. Metabolism of adrenaline after blockade of monoamine oxidase and catechol-O-methyltransferase. DE SCHAEPDRYVER AF; KIRSHNER N Science; 1961 Feb; 133(3452):586-7. PubMed ID: 13720844 [TBL] [Abstract][Full Text] [Related]
17. A monoamine oxidase inhibitor in the treatment of organic disease. MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597 [No Abstract] [Full Text] [Related]
18. Lack of relationship between inhibition of monoamine oxidase and potentiation of hexobarbital hypnosis. LAROCHE MJ; BRODIE BB J Pharmacol Exp Ther; 1960 Oct; 130():134-7. PubMed ID: 13759147 [No Abstract] [Full Text] [Related]
19. A new and safer monoamine oxidase inhibitor. ROBIE TR J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():31-48. PubMed ID: 13742239 [No Abstract] [Full Text] [Related]
20. Monoamine oxidase inhibitors and procedures for their evaluation in vivo and in vitro. OZAKI M; WEISSBACH H; OZAKI A; WITKOP B; UDENFRIEND S J Med Pharm Chem; 1960 Dec; 2():591-607. PubMed ID: 13731832 [No Abstract] [Full Text] [Related] [Next] [New Search]